₹26.6*
MRP ₹29.5
10% off
₹25.07*
MRP ₹29.5
15% CB
₹4.43 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Available Offers
PHARMA1818% OFF, applicable on orders > INR 2999
PHARMA1010% OFF, applicable on orders > INR 799
PHARMA2020% OFF, applicable on orders > INR 5499
Prescription drugWhats That
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Extra Savings
Composition :
DICLOFENAC-75MG
Manufacturer/Marketer :
Mankind Pharma Pvt Ltd
Consume Type :
PARENTERAL
Return Policy :
3 Days Returnable
Expires on or after :
Jan-27
Drug-Drug Interactions
DiclofenacMeloxicam
Critical
DiclofenacEnoxaparin
Severe
Drug-Drug Interactions
Login/Sign Up
DiclofenacMeloxicam
Critical
How does the drug interact with Gudgesic-Aq 75 mg/ml Injection 1's:
Co-administration of Gudgesic-Aq 75 mg/ml Injection 1's with Meloxicam can increase the risk or severity of gastrointestinal side effects.
How to manage the interaction:
Taking Meloxicam with Gudgesic-Aq 75 mg/ml Injection 1's is not recommended as it can possibly result in an interaction, it can be taken if your doctor has advised it. However, consult your doctor immediately if you experience symptoms such as dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness. Do not stop any medication without doctor's advise.
Co-administration of Gudgesic-Aq 75 mg/ml Injection 1's with Meloxicam can increase the risk or severity of gastrointestinal side effects.
How to manage the interaction:
Taking Meloxicam with Gudgesic-Aq 75 mg/ml Injection 1's is not recommended as it can possibly result in an interaction, it can be taken if your doctor has advised it. However, consult your doctor immediately if you experience symptoms such as dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness. Do not stop any medication without doctor's advise.
DiclofenacEnoxaparin
Severe
How does the drug interact with Gudgesic-Aq 75 mg/ml Injection 1's:
Taking Gudgesic-Aq 75 mg/ml Injection 1's with Enoxaparin can increase the risk of bleeding complications.
How to manage the interaction:
There may be a possible interaction between Gudgesic-Aq 75 mg/ml Injection 1's and Enoxaparin, but they can be taken together if your doctor has prescribed them. However, consult your doctor immediately if you experience any unusual bleeding or bruising, swelling, vomiting, blood in your urine or stools, headache, dizziness, or weakness. Do not discontinue any medications without consulting a doctor.
Taking Gudgesic-Aq 75 mg/ml Injection 1's with Enoxaparin can increase the risk of bleeding complications.
How to manage the interaction:
There may be a possible interaction between Gudgesic-Aq 75 mg/ml Injection 1's and Enoxaparin, but they can be taken together if your doctor has prescribed them. However, consult your doctor immediately if you experience any unusual bleeding or bruising, swelling, vomiting, blood in your urine or stools, headache, dizziness, or weakness. Do not discontinue any medications without consulting a doctor.
DiclofenacLeflunomide
Severe
How does the drug interact with Gudgesic-Aq 75 mg/ml Injection 1's:
Co administration of Gudgesic-Aq 75 mg/ml Injection 1's with Leflunomide may result in liver problems.
How to manage the interaction:
Co-administration of Gudgesic-Aq 75 mg/ml Injection 1's and Leflunomide can lead to an interaction; it can be taken if advised by your doctor. However, if you have a fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, loss of appetite, fatigue, nausea, vomiting, abdominal pain, dark-colored urine, light-colored stools, or yellowing of the skin or eyes. Do not stop using any medication without consulting your doctor.
Co administration of Gudgesic-Aq 75 mg/ml Injection 1's with Leflunomide may result in liver problems.
How to manage the interaction:
Co-administration of Gudgesic-Aq 75 mg/ml Injection 1's and Leflunomide can lead to an interaction; it can be taken if advised by your doctor. However, if you have a fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, loss of appetite, fatigue, nausea, vomiting, abdominal pain, dark-colored urine, light-colored stools, or yellowing of the skin or eyes. Do not stop using any medication without consulting your doctor.
DiclofenacSulindac
Severe
How does the drug interact with Gudgesic-Aq 75 mg/ml Injection 1's:
Co-administration of Gudgesic-Aq 75 mg/ml Injection 1's and sulindac can increase the risk of side effects.
How to manage the interaction:
Although there is a interaction between Gudgesic-Aq 75 mg/ml Injection 1's and sulindac, it can be taken if advised by your doctor. However, if you experience any symptoms like unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult your doctor immediately. Do not stop using any medications without a doctor's advice.
Co-administration of Gudgesic-Aq 75 mg/ml Injection 1's and sulindac can increase the risk of side effects.
How to manage the interaction:
Although there is a interaction between Gudgesic-Aq 75 mg/ml Injection 1's and sulindac, it can be taken if advised by your doctor. However, if you experience any symptoms like unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult your doctor immediately. Do not stop using any medications without a doctor's advice.
DiclofenacKetorolac
Severe
How does the drug interact with Gudgesic-Aq 75 mg/ml Injection 1's:
Coadministration of Gudgesic-Aq 75 mg/ml Injection 1's and Ketorolac can increase the risk of side effects in the gastrointestinal tract such as inflammation, bleeding and ulceration.
How to manage the interaction:
Co-administration of Gudgesic-Aq 75 mg/ml Injection 1's and Ketorolac can lead to an interaction, but it can be taken if advised by your doctor. However, if you experience any symptoms like unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult your doctor immediately. Do not stop using any medications without a doctor's advice.
Coadministration of Gudgesic-Aq 75 mg/ml Injection 1's and Ketorolac can increase the risk of side effects in the gastrointestinal tract such as inflammation, bleeding and ulceration.
How to manage the interaction:
Co-administration of Gudgesic-Aq 75 mg/ml Injection 1's and Ketorolac can lead to an interaction, but it can be taken if advised by your doctor. However, if you experience any symptoms like unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult your doctor immediately. Do not stop using any medications without a doctor's advice.
DiclofenacLomitapide
Severe
How does the drug interact with Gudgesic-Aq 75 mg/ml Injection 1's:
Taking Gudgesic-Aq 75 mg/ml Injection 1's with Lomitapide will have an additive effect and may cause liver problems.
How to manage the interaction:
There may be a possible interaction between Gudgesic-Aq 75 mg/ml Injection 1's and Lomitapide, but they can be taken together if your doctor has prescribed them. However, consult your doctor immediately if you have fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, loss of appetite, fatigue, nausea, vomiting, abdominal pain, dark colored urine, light colored stools, and/or yellowing of the skin or eyes. Do not stop using any medications without a doctor's advice.
Taking Gudgesic-Aq 75 mg/ml Injection 1's with Lomitapide will have an additive effect and may cause liver problems.
How to manage the interaction:
There may be a possible interaction between Gudgesic-Aq 75 mg/ml Injection 1's and Lomitapide, but they can be taken together if your doctor has prescribed them. However, consult your doctor immediately if you have fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, loss of appetite, fatigue, nausea, vomiting, abdominal pain, dark colored urine, light colored stools, and/or yellowing of the skin or eyes. Do not stop using any medications without a doctor's advice.
DiclofenacRamucirumab
Severe
How does the drug interact with Gudgesic-Aq 75 mg/ml Injection 1's:
Co-administration of Gudgesic-Aq 75 mg/ml Injection 1's and Ramucirumab can cause bleeding and ulcers.
How to manage the interaction:
Co-administration of Gudgesic-Aq 75 mg/ml Injection 1's and Ramucirumab can lead to an interaction; it can be taken if advised by your doctor. However, if you experience any symptoms like unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult your doctor immediately. Do not stop using any medications without a doctor's advice.
Co-administration of Gudgesic-Aq 75 mg/ml Injection 1's and Ramucirumab can cause bleeding and ulcers.
How to manage the interaction:
Co-administration of Gudgesic-Aq 75 mg/ml Injection 1's and Ramucirumab can lead to an interaction; it can be taken if advised by your doctor. However, if you experience any symptoms like unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult your doctor immediately. Do not stop using any medications without a doctor's advice.
DiclofenacPanobinostat
Severe
How does the drug interact with Gudgesic-Aq 75 mg/ml Injection 1's:
Taking Gudgesic-Aq 75 mg/ml Injection 1's with Panobinostat can increase the risk of bleeding complications.
How to manage the interaction:
There may be a possible interaction between Gudgesic-Aq 75 mg/ml Injection 1's and Panobinostat, but they can be taken together if your doctor has prescribed them. However, consult your doctor immediately if you experience any unusual bleeding or have other signs of bleeding like dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headaches. Do not discontinue any medications without consulting your doctor.
Taking Gudgesic-Aq 75 mg/ml Injection 1's with Panobinostat can increase the risk of bleeding complications.
How to manage the interaction:
There may be a possible interaction between Gudgesic-Aq 75 mg/ml Injection 1's and Panobinostat, but they can be taken together if your doctor has prescribed them. However, consult your doctor immediately if you experience any unusual bleeding or have other signs of bleeding like dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headaches. Do not discontinue any medications without consulting your doctor.
DiclofenacIndometacin
Severe
How does the drug interact with Gudgesic-Aq 75 mg/ml Injection 1's:
The combined use of Gudgesic-Aq 75 mg/ml Injection 1's and Indomethacin can increase the risk of stomach bleeding and ulcers.
How to manage the interaction:
Co-administration of Gudgesic-Aq 75 mg/ml Injection 1's and Indomethacin can lead to an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult a doctor immediately. Do not stop using any medications without a doctor's advice.
The combined use of Gudgesic-Aq 75 mg/ml Injection 1's and Indomethacin can increase the risk of stomach bleeding and ulcers.
How to manage the interaction:
Co-administration of Gudgesic-Aq 75 mg/ml Injection 1's and Indomethacin can lead to an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult a doctor immediately. Do not stop using any medications without a doctor's advice.
DiclofenacNaproxen
Severe
How does the drug interact with Gudgesic-Aq 75 mg/ml Injection 1's:
Coadministration of Gudgesic-Aq 75 mg/ml Injection 1's and Naproxen can increase the risk or severity of side effects.
How to manage the interaction:
Taking Gudgesic-Aq 75 mg/ml Injection 1's and Naproxen together can possibly result in an interaction, it can be taken if your doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact your doctor immediately. Do not stop using any medications without first talking to your doctor.
Coadministration of Gudgesic-Aq 75 mg/ml Injection 1's and Naproxen can increase the risk or severity of side effects.
How to manage the interaction:
Taking Gudgesic-Aq 75 mg/ml Injection 1's and Naproxen together can possibly result in an interaction, it can be taken if your doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact your doctor immediately. Do not stop using any medications without first talking to your doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Gudgesic-Aq 75 mg/ml Injection Substitute
Voveran SR 75 Tablet 10's
₹9.86per tabletDynapar AQ Injection 5 x 1 ml
₹35.64per tabletVoveran AQ Injection 1 ml
₹32.00per tabletNAC SR 75MG TABLET
₹3.87per tabletDynapar SR 75 mg Tablet 10's
by AYUR
₹9.02per tablet
Product Substitutes
Alcohol
Consult your doctor
It is not known if alcohol affects Gudgesic-Aq 75 mg/ml Injection. Please consult your doctor for more information. However, limiting alcohol consumption is recommended while on treatment with Gudgesic-Aq 75 mg/ml Injection.
Pregnancy
Caution
Gudgesic-Aq 75 mg/ml Injection is not recommended for use in the last three months of pregnancy as it may harm the unborn child or cause problems at delivery. Hence, if you are pregnant or planning pregnancy, inform your doctor before receiving Gudgesic-Aq 75 mg/ml Injection. Your doctor may prescribe this medicine if the benefits outweigh the risks.
Breast Feeding
Caution
If you are breastfeeding, inform your doctor before receiving Gudgesic-Aq 75 mg/ml Injection. Your doctor may prescribe this medicine if the benefits outweigh the risks.
Driving
Caution
Occasionally, Gudgesic-Aq 75 mg/ml Injection may cause dizziness and tiredness. Drive or operate machinery only if you are alert.
Liver
Consult your doctor
If you have a history of liver disease, inform your doctor before receiving Gudgesic-Aq 75 mg/ml Injection. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.
Kidney
Caution
If you have a history of kidney diseases, inform your doctor before receiving Gudgesic-Aq 75 mg/ml Injection. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.
Children
Caution
Gudgesic-Aq 75 mg/ml Injection is not recommended for children.
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
